Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice
- 9 May 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 233 (10) , 7165-7177
Abstract
CD73 facilitates tumor growth by upregulation of the adenosine (immunosuppressive factor) in the tumor microenvironment, however, its precise molecular mechanisms is not precisely understood. Regarding the importance of angiogenesis in tumor development and spreading, we decided to assign the anti‐angiogenic effects of CD73 suppression. We used chitosan lactate (ChLa) nanoparticles (NPs) to deliver CD73‐specific small interfering RNA (siRNA) into cancer cells. Our results showed that treatment of the 4T1 cells with CD73‐specific siRNA‐loaded NPs led to potent inhibition of cancer cell proliferation and cell cycle arrest, in vitro. This growth arrest was correlated with downregulation of angiogenesis‐related molecules including vascular endothelial growth factor (VEGF)‐A, VEGF‐R2, interleukin (IL)‐6, and transforming growth factor (TGF)‐β. Moreover, administration of NPs loaded with CD73‐siRNA into 4T1 breast cancer‐bearing mice led to tumor regression and increased mice survival time accompanied with downregulation of angiogenesis (VEGF‐A, VEGF‐R2, VE‐Cadherin, and CD31) and lymphangiogenesis (VEGF‐C and LYVE‐1)‐related genes in the tumor site. Furthermore, the expression of angiogenesis promoting factors including IL‐6, TGF‐β, signal transducer, and activator of transcription (STAT)3, hypoxia inducible factor (HIF)‐1α, and cyclooxygenase (COX)2 was decreased after the CD73 suppression in mice. Moreover, analysis of leukocytes derived from the tumor samples, spleen, and regional lymph nodes showed that they had lower capability for secretion of angiogenesis promoting factors after CD73‐silencing. These results indicate that suppression of tumor development by downregulation of CD73 is in part related to angiogenesis arrest. These findings imply a promising strategy for inhibiting tumor growth accompanied with suppressing the angiogenesis process.Keywords
Funding Information
- Tabriz University of Medical Sciences (58212)
- Tehran University of Medical Sciences and Health Services (24869)
This publication has 40 references indexed in Scilit:
- Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine modelCancer Immunology, Immunotherapy, 2017
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancerJournal of Cellular Physiology, 2017
- Targeting of crosstalk between tumor and tumor microenvironment by β‐D mannuronic acid (M2000) in murine breast cancer modelCancer Medicine, 2017
- Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancerCancer Immunology, Immunotherapy, 2016
- The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosisInflammation Research, 2016
- Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticlesTumor Biology, 2016
- Anti‐CD73 therapy impairs tumor angiogenesisInternational Journal of Cancer, 2013
- Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventionsTumor Biology, 2013
- The role of natural killer T cells in B cell malignanciesTumor Biology, 2013
- RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasionClinical & Experimental Metastasis, 2007